Regulatory bodies Flashcards

1
Q

There are several key regulatory boards:

A
  1. The Committee for Medicinal Products for Human Use (CHMP) is responsible for vaccines in Europe, defining what vaccines/
    vaccine components are.
  2. The EMEA is responsible for guidelines on Biologicals. Any changes of biologic manufacturing must be clarified
  3. The Paediatric Committee (PDCO)
  4. The Committee for Advanced Therapies (CAT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vaccines must be

A

safe, with low toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

They must offer

A

effective protection against infective agents to rapidly generate herd immunity and ideally, produce long-lived immunity to reduce the amount of booster doses required; this reduces the cost involved and complexity of vaccine regimens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

They should be cheap

A

or cost-effective, as they will be administered widely. They should contain only purified components (i.e. the key antigens only): for intracellular organisms, CTL and Abs are needed, for extracellular organisms, only Abs are needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

They should also be stable

A

and be correctly formulated (uniformity of dose, adjuvant, preservative & moisture content).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Future vaccine development

A

Mycobacterium tuberculosis (TB), HIV and plasmodium falciparum (malaria) are the three biggest killers, with vaccines in development. New vaccine strategies are needed to deal with complex, intractable pathogens such as HIV, TB and malaria. These involve determining correlates of protective immunity, optimising immunogens and developing a vaccination strategy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Attenuated vaccine is not viable for HIV

A

as it destroys CD4+ cells, dampens the immune response and relentlessly mutates, meaning that finding a target is very difficult. However, the RV-144 trial involved showed 30% efficacy, with highest degree of protection between 6-12 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly